GLEEVEC
Active Ingredient: IMATINIB (IMATINIB MESYLATE)
Product Overview
About GLEEVEC
GLEEVEC is a prescription medication containing the active ingredient Imatinib (Imatinib Mesylate), a tyrosine kinase inhibitor used in the treatment of certain types of cancer. It is specifically designed to target and block the activity of specific enzymes responsible for the growth and spread of cancer cells.
Key Benefits & Uses
- Treatment of Chronic Myeloid Leukemia (CML) in adults and children, including those with the Philadelphia chromosome-positive (Ph+) subtype.
- Treatment of Gastrointestinal Stromal Tumors (GISTs) in adults.
- Adjuvant treatment of adult patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) after initial treatment.
Active Ingredient & Action
Imatinib (Imatinib Mesylate) works by selectively inhibiting the activity of tyrosine kinases, enzymes that play a crucial role in the signaling pathways that control cell growth and division. By blocking these enzymes, Imatinib prevents the proliferation of cancer cells and induces apoptosis (cell death). This targeted approach helps to minimize the harm to healthy cells and reduce the risk of side effects.
Important Notes
GLEEVEC is available in tablet form and should be taken orally with water. It is essential to follow the recommended dosage and treatment schedule as prescribed by your healthcare provider. Regular monitoring of blood cell counts and liver function is necessary to ensure the safe and effective use of GLEEVEC. Patients with a history of heart disease or other medical conditions should inform their healthcare provider before starting treatment with GLEEVEC.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
